[1] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南.实用肝脏病杂志,2013,16（3）：210-216.
[2] Bathgate A J,Garden O J,Forsythe J R,et al. The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J,1999,44（1）:9-10.
[3] 谢仕斌, 吴元凯, 朱建芸, 等. 慢加急性肝衰竭预后评分系统的建立与评估. 中山大学学报（医学科学版）,2011,32（6）:834-840.
[4] Kamath P S,Wiesner R H,Malinchoc M,et al. A model to predict survival in patients with end-stage liver disease. Hepatology,2001,33（2）:464-470.
[5] Malinchoc M,Kamath P S,Gordon F D,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemicshunts. Hepatology,2000,31（4）:864-871.
[6] Wiesner R,Edwards E,Freeman R,et al. Model for end-stage liver disease（MELD）and allocation of donor livers. Gastroenterology,2003,124（1）:91-96.
[7] Huo T I,Lin H C,Wu J C,et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant,2006,20（2）:188-194.
[8] Fernandez J,Navasa M,Planas R,et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology,2007,133（3）:818-824.
[9] Zheng Y B,Xie D Y,Gu Y R,et al. Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure:a retrospective cohort study. Clin Invest Med,2012,35（2）:E75-E85.
[10] 刘雯. MELD评分评估血浆置换治疗慢性乙型肝炎肝衰竭的疗效. 实用肝脏病杂志,2011,14（1）:29-30.
[11] 郑盛,殷芳,刘海. 四种评分系统预测慢性肝衰竭预后的价值比较. 实用肝脏病杂志,2011,14（2）:102-105.
[12] Cardoso NM,Silva T,Basile-Filho A,et al. A new formula as a predictive score of post-liver transplantation outcome:Postoperative MELD-lactate. Transplant Proc,2014,46（5）:1407-1412.
[13] Kim JM,Kwon CH,Joh JW,et al. Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A. Ann Surg Treat Res,2014,86（3）:122-129. |
